[Federal Register Volume 61, Number 213 (Friday, November 1, 1996)]
[Notices]
[Page 56559]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-28261]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


National Cancer Institute; Notice of Meeting

    Notice is hereby given of the meeting of the Advisory Committee to 
the Director, National Cancer Institute, Working Group on Developmental 
Diagnostics November 5-6, 1996 in Conference Room D, Natcher Building, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland.
    This meeting will be open to the public on November 5, 1996 from 
8:30 a.m. to approximately 5 p.m., during which presentations will be 
made on existing clinical specimen resources and issues related to the 
use of these resources for basic and clinical cancer research.
    The meeting will be closed to the public on November 6, 1996 from 9 
a.m. to approximately 11 a.m. for discussion of confidential issues 
relating to the discussion and evaluation of issues pertaining to 
programmatic areas and/or NCI Personnel. These discussions will reveal 
confidential personal information including consideration of personnel 
qualifications and performance, the competence of individual 
investigators and similar matters, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy and 
premature disclosure of recommendations which would inhibit the final 
outcome and subsequent implementation of recommendations.
    Information pertaining to the meeting may be obtained from Ms. 
Susan J. Waldrop, Executive Secretary, Developmental Diagnostics 
Working Group, National Cancer Institute, Office of Science Policy, 
Building 31, Room 3A11, 31 Center Drive, MSC 2440, Bethesda, MD 20892 
(301) 496-1458. Attendance by the public will be limited to space 
available. Individuals who plan to attend and need special assistance 
such as sign language interpretation or other reasonable accommodations 
should contact Ms. Waldrop in advance of the meeting.

    Dated: October 28, 1996.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 96-28261 Filed 10-30-96; 2:25 pm]
BILLING CODE 4140-01-M